What Is Bone Age – How Doctors Test Skeletal Maturity

Bone age is a measure of how mature a child’s skeleton is compared to their chronological age, assessed by examining how much the growth plates (soft cartilage zones at the ends of bones) have developed. Doctors test it using a left-hand and wrist X-ray, then compare the image against standard reference atlases. Results guide treatment for growth disorders in children typically between ages 2 and 18.

The Mechanics Behind Skeletal Maturity Scoring

Bone age, formally called skeletal age, tells a physician how far a child’s bones have progressed through their biological growth timeline, which may run ahead of or behind the calendar age. A child who is 10 years old chronologically might have a bone age of 8 or 12, and both findings carry meaningful clinical information.

The concept rests on the behavior of growth plates, also called epiphyseal plates, which are cartilaginous regions near the ends of long bones where new bone tissue is actively produced during childhood and adolescence. Over time these plates progressively harden, a process called ossification (the conversion of cartilage into solid bone), and they eventually fuse completely, signaling the end of linear growth. The degree of ossification visible on an X-ray is what radiologists and pediatric endocrinologists use to assign a bone age.

Bone age and chronological age are not always equal, and that gap is precisely where the clinical insight lives. The difference between the two numbers, expressed in years, is called the bone age discrepancy and is the primary data point physicians act on when making treatment decisions.

Key Finding: Growth plate fusion is irreversible. Once a plate closes, that bone can no longer grow in length, making accurate timing of bone age assessment critically important for treatment decisions.

The Full Biological Process: How Bones Actually Mature

Understanding why bone age can be read from an X-ray requires a brief look at the biology driving skeletal development from birth onward.

At birth, much of the skeleton is still cartilage. The process of endochondral ossification (the step-by-step replacement of cartilage with mineralized bone tissue) begins before birth and continues in a precise, genetically programmed sequence through adolescence. Primary ossification centers form in the shafts of long bones during fetal development, while secondary ossification centers appear at the rounded ends of bones, called epiphyses, at predictable ages after birth.

The carpal bones of the wrist appear as secondary ossification centers at well-documented intervals. The capitate and hamate (two of the eight wrist bones) are typically the first to appear, usually visible on X-ray by 3 to 6 months of age. The pisiform is generally the last carpal to ossify, typically appearing around ages 8 to 12. This predictable sequence is what makes the hand and wrist such a reliable biological clock.

Hormones drive this entire process. Growth hormone (GH), secreted by the pituitary gland (a pea-sized gland at the base of the brain), stimulates the liver to produce insulin-like growth factor 1 (IGF-1), which directly acts on growth plate cells called chondrocytes to promote division and new bone formation. Sex hormones, particularly estrogen in both girls and boys, play the critical role of accelerating plate fusion during puberty. This is why puberty initially causes a growth spurt but ultimately ends growth by closing the plates.

Thyroid hormone is equally important. Children with untreated hypothyroidism (an underactive thyroid gland) show severely delayed bone age because thyroid hormone is essential for normal chondrocyte function. This relationship is one reason bone age testing is a standard part of the workup for any child with unexplained growth failure.

Why a Single X-Ray of the Left Hand Reveals So Much

The left hand and wrist X-ray is the standard site for bone age testing because it contains 29 bones including the radius, ulna, eight carpal bones, five metacarpals, and fourteen phalanges, all of which ossify on a predictable, well-documented schedule.

Physicians prefer the left hand by convention, established through the two most widely used reference systems in the United States: the Greulich and Pyle atlas (published in 1959 based on healthy American children) and the Tanner-Whitehouse method (a point-scoring approach scoring 20 specific bones individually). Both systems give clinicians a structured way to translate X-ray appearance into a bone age number measured in years and months.

The radiation dose from a single hand X-ray is remarkably low, generally around 0.00001 Sv (sieverts, the unit measuring radiation absorbed by the body), roughly equivalent to a few hours of natural background radiation exposure. Parents in the United States frequently ask about radiation safety, and this figure consistently reassures them.

Why the Left Hand Specifically and Not the Right

The choice of the left hand is a standardization decision rather than a biological one. There is no meaningful difference in skeletal maturity between left and right hands in most children. Using the left hand consistently across all patients and all reference atlases ensures that measurements from different labs and different time points are directly comparable. If a child has a left-hand injury or congenital difference, the right hand can be used with a notation in the report.

Specific Bones Radiologists Examine and What They Look For

A radiologist reading a bone age film systematically evaluates specific anatomical features across multiple bones rather than simply glancing at the hand as a whole.

Key features assessed on each bone:

• Epiphyseal size and shape: The rounded cap of bone at the end of each finger bone grows and changes shape in a predictable way, and radiologists compare its width relative to the shaft width.
• Epiphyseal density: Early ossification centers appear faint and wispy, becoming denser and more clearly defined as they mature.
• Capping: When an epiphysis begins to wrap around or cap the top of the shaft, it signals a specific level of maturity within the Tanner-Whitehouse scoring system.
• Fusion: Partial or complete bridging between the epiphysis and shaft indicates late-stage skeletal maturity.
• Carpal bone outline definition: The edges of carpal bones become smoother and more sharply defined as ossification progresses.

Bones most heavily weighted in Greulich-Pyle assessment:

How the Greulich and Pyle Atlas Works in Practice

The Greulich and Pyle (G&P) method is the most commonly used bone age technique in American pediatric radiology because it is fast and practical for high-volume clinical settings.

A radiologist places the child’s hand X-ray beside photographic standards in the atlas, which organizes reference images by sex and by age from birth through age 19. The clinician finds the atlas image that most closely resembles the patient’s X-ray and assigns that image’s labeled age as the child’s bone age. The entire reading typically takes under 5 minutes.

The Tanner-Whitehouse TW3 method, by contrast, assigns point scores to 20 bones separately and adds them into a total that maps onto a bone age scale. It is more time-consuming but provides greater precision and is often preferred in research settings and for monitoring patients on growth hormone therapy.

Other Reference Methods Used Less Frequently in the U.S.

While Greulich-Pyle dominates American practice, several other validated methods exist and are encountered in research literature or international clinical settings.

• Fels method: Developed at the Fels Research Institute in Ohio using a U.S. longitudinal study population, producing a bone age estimate with a stated standard deviation and scoring individual bones and carpal bones separately.
• TWII and TW3: Earlier and later versions of the Tanner-Whitehouse system, with TW3 published in 2001 updating scoring tables based on more recent European data reflecting secular trends in puberty timing.
• Gilsanz and Ratib atlas: A more recent photographic atlas using digital radiographs rather than film, providing sharper reference images that some radiologists find easier to match against modern digital X-rays.
• Eklof and Ringertz method: A Scandinavian system occasionally referenced in literature but rarely used in routine U.S. clinical practice.

Automated AI Scoring: BoneXpert and Beyond

Manual atlas comparison carries inter-reader variability, meaning two radiologists may assign slightly different bone ages from the same film. This meaningful challenge has driven the rise of computer-aided bone age software.

BoneXpert, a CE-marked and FDA-cleared algorithm used widely across U.S. academic medical centers, analyzes the digital X-ray and returns a bone age estimate in seconds with a precision of approximately plus or minus 0.5 years. Studies published in peer-reviewed journals confirm its accuracy is comparable to experienced pediatric radiologists for children between ages 2 and 17.

Additional AI platforms including iBolivar and deep-learning models developed at institutions such as Stanford University have demonstrated strong performance in multicenter validation studies. These tools are increasingly integrated into picture archiving and communication systems (PACS, the digital infrastructure hospitals use to store and display medical images), allowing radiologists to receive an automated estimate before completing their own review.

How BoneXpert Generates Its Estimate

BoneXpert uses an active appearance model, a computer vision technique that learns the expected shape and texture of each bone from thousands of training X-rays. It automatically identifies 15 bones in the hand and wrist, measures their maturity individually using criteria derived from both the Greulich-Pyle and Tanner-Whitehouse frameworks, and combines those individual assessments into a single bone age output. The system also flags images where bone quality or positioning is poor enough to reduce confidence in the result, prompting the radiologist to apply additional scrutiny.

A notable feature of BoneXpert is its bone health index (BHI) output, a secondary measurement of cortical bone density that can flag children at risk for low bone mineral density even during a routine bone age assessment, adding diagnostic value beyond skeletal maturity alone.

Bone Age Versus Chronological Age: What the Gap Means

The clinical value of bone age emerges from comparing it to a child’s actual birth-based age. The table below summarizes the standard interpretive framework used by U.S. pediatric endocrinologists.

A delayed bone age is not automatically a bad sign. In children with constitutional delay of growth and puberty (a normal variant where a child grows slowly but is otherwise healthy), a bone age that lags by 2 to 3 years actually signals that more growing time remains, predicting a normal adult height eventually reached later than peers.

What a Normal Result Actually Looks Like

Families sometimes expect bone age to match chronological age exactly and become concerned when there is any discrepancy. Clinicians consistently explain that a gap of up to 1 year in either direction is considered well within the normal range and requires no further investigation on its own. A gap of 1 to 2 years warrants clinical context but is not independently diagnostic of any condition. It is only when the discrepancy exceeds 2 years consistently, or when it is accompanied by abnormal growth velocity or other clinical signs, that further workup is indicated.

Growth Velocity: The Measurement Bone Age Cannot Replace

Bone age is a powerful tool, but it does not stand alone. Growth velocity, the rate at which a child grows over a defined period (measured in centimeters per year), provides information that a single bone age reading cannot.

A child can have a delayed bone age and still be growing at a completely normal velocity of 5 to 6 cm per year during mid-childhood, which is reassuring. The same child with a delayed bone age but a growth velocity of only 3 cm per year presents a much more concerning picture that strongly suggests a pathological process requiring investigation.

Pediatric endocrinologists plot growth velocity on CDC growth charts (the standardized reference charts developed by the Centers for Disease Control and Prevention based on large U.S. population samples) and cross-reference the pattern with bone age to build a complete clinical picture. The combination of a significantly delayed bone age, low growth velocity, and low IGF-1 blood levels forms the diagnostic triad most strongly associated with growth hormone deficiency.

Predicting Adult Height From Skeletal Data

One of the most practically valuable applications of bone age testing is adult height prediction, which pediatric endocrinologists use to counsel families and make treatment decisions.

The most widely cited formula in U.S. clinical practice is the Bayley-Pinneau method, which uses bone age and current height to look up a predicted adult stature from reference tables. A related approach, the Roche-Wainer-Thissen (RWT) formula, incorporates bone age, current height, current weight, and mid-parental height (the average of the biological parents’ heights adjusted by 6.5 cm for sex) to generate a prediction.

These predictions carry a margin of error of roughly plus or minus 2 inches (5 cm), which clinicians clearly communicate to families. The predictions become more accurate as a child approaches the end of puberty when growth plates near full fusion. Bone age is also used to determine whether a child has finished growing: once bone age reaches approximately 14 to 15 years in girls and approximately 16 to 17 years in boys, the growth plates are typically fused and linear growth has ended.

Mid-Parental Height and Its Role Alongside Bone Age

Mid-parental height (MPH), also called the target height, is calculated as follows:

• For boys: Father’s height in inches plus mother’s height in inches plus 5, divided by 2.
• For girls: Father’s height in inches plus mother’s height in inches minus 5, divided by 2.

A child growing significantly below their mid-parental height target percentile, combined with a delayed bone age, raises concern that growth is being suppressed by an underlying condition. A child tracking well within 2 inches of their MPH target with a delayed bone age and normal growth velocity most likely has constitutional delay rather than pathology.

The Bone Age Workup: What Happens Before and After the X-Ray

A bone age X-ray rarely arrives in isolation. It is one component of a structured diagnostic sequence that U.S. pediatric endocrinologists follow.

Typical evaluation sequence when bone age is ordered:

1. Growth history review: The physician plots all available height and weight measurements onto growth charts to establish growth velocity over time.
2. Physical examination: Pubertal staging using the Tanner staging system (a standardized five-stage scale describing breast, pubic hair, and genital development) is performed to document where the child is in puberty.
3. Mid-parental height calculation: Target height is established from parental measurements.
4. Bone age X-ray ordered: Left hand and wrist film obtained and read.
5. Blood work: Depending on findings, labs may include IGF-1, IGF-binding protein 3 (IGFBP-3), thyroid function tests (TSH and free T4), a complete metabolic panel, complete blood count, celiac antibodies, and a karyotype (chromosomal analysis) if Turner syndrome is suspected.
6. Growth hormone stimulation testing: If GH deficiency is suspected, a formal stimulation test is performed in which medications like arginine, clonidine, glucagon, or levodopa are given to provoke GH release while blood is drawn at timed intervals. A peak GH response below 10 ng/mL is the traditional threshold used in the U.S. to diagnose GH deficiency, though some centers use 7 ng/mL.
7. MRI of the brain and pituitary: Ordered when GH deficiency is confirmed to look for structural causes such as a pituitary tumor, craniopharyngioma, or congenital abnormality.
8. Follow-up bone age: Repeated at 6 to 12 month intervals during treatment to monitor response.

Conditions That Drive Bone Age Testing in U.S. Pediatric Clinics

Pediatric endocrinologists, pediatric radiologists, and general pediatricians across the United States order bone age X-rays for a well-defined set of clinical scenarios.

Common indications for bone age testing:

1. Short stature below the 3rd percentile for age and sex on standard CDC growth charts.
2. Tall stature above the 97th percentile raising concern about a hormonal cause.
3. Precocious puberty beginning before age 8 in girls or age 9 in boys.
4. Delayed puberty with no breast development by age 13 in girls or testicular enlargement by age 14 in boys.
5. Monitoring growth hormone therapy to track treatment response and remaining growth potential.
6. Evaluation of hypothyroidism or hyperthyroidism affecting skeletal development.
7. Turner syndrome workup, a chromosomal condition affecting females causing short stature.
8. Congenital adrenal hyperplasia, a group of inherited disorders affecting adrenal hormone production.
9. Assessing bone age in adoption cases where birth records are unavailable or uncertain.
10. Forensic or legal age estimation in adolescents without documentation.

How Bone Age Guides Growth Hormone Treatment Decisions

Growth hormone therapy is one of the most consequential areas where bone age data directly shapes clinical decision-making, making accurate and serial bone age assessment critically important in this patient population.

Recombinant human growth hormone (rhGH), administered as a daily subcutaneous injection (an injection into the fat layer just beneath the skin), is FDA-approved for multiple indications in children including GH deficiency, Turner syndrome, Prader-Willi syndrome (a genetic disorder causing poor growth and other complications), small for gestational age status failing to catch up by age 2, idiopathic short stature (short stature without an identified cause), and SHOX gene deficiency (a specific genetic cause of short stature).

Bone age guides rhGH therapy in three specific ways:

• Treatment initiation: A significantly delayed bone age with remaining growth potential provides justification for starting therapy while meaningful growth can still occur.
• Dose adjustment: As bone age advances during treatment, physicians may adjust the dose to balance growth promotion against the risk of advancing bone age too rapidly, which would prematurely close growth plates.
• Treatment discontinuation: When bone age reaches approximately 14 years in girls or 16 years in boys and growth velocity falls below 2 to 2.5 cm per year, treatment is typically tapered and stopped because remaining growth potential is negligible.

The cost of rhGH therapy in the United States is substantial, often ranging from $10,000 to $60,000 per year depending on dose and the child’s size, making insurance authorization a significant practical concern for families. Bone age documentation is a required component of most insurance prior authorization submissions for growth hormone.

Precocious Puberty: When Advanced Bone Age Becomes Urgent

An advanced bone age is particularly concerning when it accompanies signs of early puberty, because the combination can predict a paradoxical outcome where a child who is tall now ends up shorter than expected as an adult.

Central precocious puberty (CPP), in which the brain’s hypothalamic-pituitary axis (the hormonal signaling chain between the brain and gonads) activates early, causes both early pubertal development and accelerated bone maturation. A 7-year-old girl with breast development and a bone age of 10 or 11 years may be on a trajectory to reach menarche (first menstrual period) within a year or two and stop growing at a height well below her genetic potential.

Treatment with GnRH agonists (gonadotropin-releasing hormone agonists, medications that suppress the pituitary signals driving puberty), such as leuprolide acetate (brand name Lupron Depot, administered as a monthly or quarterly injection) or histrelin acetate (brand name Supprelin, a yearly implant placed under the skin of the upper arm), effectively pauses puberty and slows bone age advancement. Bone age X-rays are obtained every 6 to 12 months during treatment to confirm that skeletal maturation is decelerating appropriately in response to therapy.

The Role of Growth Plates Across Developmental Stages

Growth plates do not all fuse at the same time, and understanding this sequence gives clinicians meaningful diagnostic resolution across different ages and conditions.

The hand and wrist plates are the first to be studied because they ossify on a precise, well-charted timeline from early childhood onward. The knee (distal femur and proximal tibia) and hip (proximal femur) are alternative sites used in specific clinical situations, particularly when hand X-rays are inconclusive or when the child is very young (under 2 years), where wrist bone development is too limited to score reliably.

In infants and toddlers under 2 years, clinicians sometimes use the knee or foot instead because more ossification centers are visible there at that age. For children with skeletal dysplasias (inherited conditions causing abnormal bone development), a full skeletal survey covering multiple body regions may be ordered rather than a single-site assessment.

The Growth Plate Fusion Sequence Across the Whole Body

The approximate fusion timeline across major skeletal sites, from earliest to latest, is as follows:

The medial clavicle is the single most important site for forensic age estimation in young adults precisely because it is the last plate to fuse, providing skeletal information into the mid-twenties when all other growth plates have already closed.

Bone Age in Athletes and the Sports Medicine Context

Bone age assessment has a growing role in sports medicine and youth athletics, particularly for contact sports where a significant mismatch in physical maturity between same-age competitors creates injury risk.

Two 13-year-old boys on the same football team may have dramatically different bone ages, one at 11 years and one at 15 years, producing a large difference in physical size, strength, and skeletal fragility. The early-maturing athlete with an advanced bone age has growth plates that are closer to fusion and therefore more mechanically stable, while the late-maturing athlete with open, cartilaginous plates is more vulnerable to Salter-Harris fractures (growth plate fractures classified by a five-category system describing where the fracture line passes through the growth plate, physis, and surrounding bone).

Some youth sports organizations and researchers have proposed using bone age combined with measures of bio-banding (grouping athletes by biological maturity stage rather than chronological age) to create safer and more developmentally appropriate competitive categories. The English Football Association and several European soccer academies have implemented bio-banding pilots using Tanner staging and bone age data. This application remains less formalized in U.S. youth sports but is an active area of research and discussion among sports medicine physicians, pediatric endocrinologists, and athletic trainers.

Stress fractures at the growth plate, called apophysitis (inflammation at the point where a tendon attaches to a growing bone), are also more common in athletes whose bone age indicates rapid skeletal advancement during puberty. Conditions like Osgood-Schlatter disease (apophysitis at the tibial tubercle, the bony bump just below the knee) and Sever’s disease (apophysitis at the heel bone) are recognized as growth plate vulnerabilities in athletically active adolescents.

Nutrition, Chronic Illness, and Their Measurable Impact on Skeletal Maturity

Bone age is sensitive to systemic factors beyond hormones, and chronic illness or nutritional deficiency can significantly delay skeletal maturation independently of any endocrine disorder.

Malnutrition, including protein-calorie deficiency, delays bone age because adequate macronutrients and micronutrients are essential for growth plate chondrocyte function and mineralization. Children with inflammatory bowel disease (IBD, including Crohn’s disease and ulcerative colitis), celiac disease (an autoimmune condition causing intestinal damage triggered by gluten), cystic fibrosis, chronic kidney disease, or congenital heart disease frequently show bone age delays proportional to the severity and duration of their illness.

Key nutrients specifically linked to bone age progression include:

• Vitamin D: Essential for calcium absorption and bone mineralization, with deficiency causing rickets, a condition producing bowed legs, soft bones, and severely delayed bone age.
• Calcium: The primary mineral incorporated into bone matrix during ossification.
• Zinc: Required for growth hormone receptor signaling and chondrocyte proliferation.
• Iron: Deficiency anemia impairs growth through multiple mechanisms including IGF-1 suppression.

When a child’s bone age delay is explained entirely by an identified chronic illness or nutritional deficiency, successful treatment of the underlying condition typically results in catch-up growth, a period of accelerated growth velocity during which bone age advances more rapidly than usual to partially or fully close the gap with chronological age.

Psychological and Family Dimensions of Bone Age Testing

The experience of having a child’s growth evaluated, and receiving bone age results, carries psychological weight for families that clinicians increasingly recognize as a meaningful part of care.

Parents of short children frequently report feelings of guilt, concern, and social pressure well before they reach a specialist’s office. A bone age result showing significant delay can either reassure families in cases of constitutional delay or generate new anxiety when it points toward a diagnosis requiring treatment. Pediatric endocrinologists and pediatric psychologists at major children’s hospitals such as Boston Children’s Hospital, Children’s Hospital of Philadelphia, and Texas Children’s Hospital have developed family counseling resources specifically addressing the emotional dimensions of growth disorder evaluation.

Children themselves, particularly adolescents experiencing delayed puberty, often face significant social and psychological consequences from appearing younger than peers. Research published in journals including Pediatrics and the Journal of Clinical Endocrinology and Metabolism documents elevated rates of social anxiety, reduced self-esteem, and academic difficulty in adolescents with delayed bone age and constitutional growth delay. These findings have strengthened clinical arguments for offering short-term low-dose testosterone therapy to adolescent males with constitutional delay who are experiencing significant psychosocial distress, even when the delay is not caused by a pathological condition.

Cost, Access, and Insurance Coverage in the United States

A bone age X-ray is a standard, widely available imaging study in the U.S. The out-of-pocket cost without insurance typically ranges from $50 to $200 depending on the facility, with hospital-based radiology departments generally charging more than freestanding imaging centers.

Most major U.S. health insurers, including Medicaid, Medicare (when applicable for pediatric patients), and commercial plans, cover bone age X-rays when ordered with appropriate clinical documentation supporting medical necessity. A referral from a pediatrician to a pediatric endocrinologist (a physician specializing in hormone-related conditions in children) or directly to a pediatric radiologist is the typical pathway.

Results are usually available within 24 to 48 hours at most facilities. In centers using AI-assisted platforms like BoneXpert, a preliminary automated result may be available within minutes of image acquisition, which is particularly valuable in busy academic children’s hospitals serving large patient volumes.

Telehealth and Remote Bone Age Review

A meaningful gap in access exists between urban academic medical centers and rural or underserved communities across the United States. Children in rural areas may wait weeks to months for an appointment with a pediatric endocrinologist, and the nearest pediatric radiology specialist may be hours away.

Teleradiology (the remote transmission and reading of medical images by radiologists at a different location) has substantially improved bone age access. A general practitioner in a rural clinic can order a digital X-ray at a local imaging center and transmit the image electronically to a pediatric radiologist at a major children’s hospital for a formal bone age read, often within 24 hours. Combined with telehealth video consultations, this workflow allows pediatric endocrinologists at academic centers to manage growth disorder patients across large geographic areas without requiring the family to travel for every visit.

Limitations Physicians Actively Communicate to Families

Bone age testing is a powerful clinical tool, but it carries important limitations that responsible clinicians consistently discuss with families.

The Greulich and Pyle reference population was collected from white, middle-class American children in the 1930s and 1940s, which does not fully represent the ethnic and socioeconomic diversity of today’s U.S. pediatric population. Research has demonstrated that bone age norms may differ across racial and ethnic groups, with studies noting that African American children may have more advanced bone ages on average compared to G&P norms. Several research groups are actively working on updated, more diverse reference standards.

Bone age also represents a snapshot, not a trajectory. A single measurement captures where skeletal maturity stands at one moment. Serial measurements taken 6 to 12 months apart provide far more clinically actionable information by showing whether bone age is advancing faster or slower than chronological age over time.

Conditions Where Bone Age Assessment Is Less Reliable

Certain clinical situations reduce the reliability of standard bone age assessment and require additional consideration:

• Skeletal dysplasias: Conditions like achondroplasia (the most common form of dwarfism, caused by a mutation in the FGFR3 gene) and hypochondroplasia produce abnormal bone shapes that do not match standard atlas images, making assignment of a meaningful bone age difficult or impossible with G&P.
• Severe malnutrition or chronic illness: Bone shape may be normal but severely delayed in a way that exceeds the lower end of the reference atlas range, producing floor-effect readings.
• Children with significant hand or wrist anomalies: Congenital limb differences, prior fractures with deformity, or syndromic conditions affecting hand development may make standard assessment unreliable.
• Premature infants: Corrected gestational age must be used rather than chronological age for any bone age interpretation in children born significantly preterm, particularly in the first 2 to 3 years of life.

Important Note: Bone age is one data point in a broader clinical picture. Physicians always interpret it alongside growth velocity, pubertal staging, hormone levels, family history, and nutrition when making diagnostic or treatment decisions.

Forensic and Non-Medical Uses of Bone Age Assessment

Beyond pediatric medicine, bone age assessment plays a meaningful role in forensic age estimation, a practice used in U.S. immigration courts, criminal proceedings involving juveniles, and international adoption proceedings when birth documentation is unavailable.

Forensic specialists use hand X-rays, dental development, and sometimes clavicle (collarbone) X-rays together because the medial clavicle growth plate is the last growth plate to fuse in the body, typically completing fusion between ages 25 and 30. This makes clavicle assessment particularly valuable for distinguishing adults from older adolescents.

The Society for Forensic Radiology and Imaging and the American College of Radiology have published guidance emphasizing that bone age ranges used in forensic contexts should be interpreted with wide confidence intervals, and that no single radiographic finding can definitively establish age to the level of legal certainty. Courts consider bone age evidence alongside other documentation rather than as a standalone determinant.

Dental Age as a Complementary Tool

Forensic age estimation typically pairs radiographic bone age with dental age assessment, performed by a forensic odontologist (a dental specialist in forensic applications) using panoramic dental X-rays (a wide-view X-ray showing all teeth simultaneously). The development and eruption sequence of permanent teeth, particularly third molars (wisdom teeth), provides age-related information that extends into the late teens and early twenties, complementing and cross-checking the skeletal data from hand and clavicle X-rays.

The American Board of Forensic Odontology provides standards for dental age estimation used in U.S. legal proceedings, and joint reports from both a forensic radiologist and a forensic odontologist are considered best practice when comprehensive age estimation is required.

What Families Experience During the Test

The bone age X-ray is one of the simplest, least invasive imaging studies a child undergoes. The entire appointment, from check-in to leaving the facility, generally takes 15 to 30 minutes.

The child places their left hand flat on a digital X-ray plate, and the technologist positions the hand in a standardized posterior-anterior projection (palm facing down). The exposure takes less than one second. No contrast dye, no sedation, and no special preparation are needed. Children as young as 2 years can complete the study successfully with a calm technologist and a parent present.

How to Prepare Your Child for a Bone Age X-Ray

Most children experience no anxiety about this test once it is explained to them clearly. Practical preparation tips that pediatric radiology departments across the U.S. commonly provide to families include:

• Remove jewelry and nail polish from the left hand before the appointment, as metal objects and some nail polish formulations can interfere with image quality.
• Wear short sleeves or loose sleeves that can easily be pushed above the wrist.
• Explain to the child in age-appropriate terms that the machine takes a picture of the bones in their hand and that there is no pain, no shot, and no loud noise.
• No fasting is required, unlike blood draws that may involve dietary restrictions before the appointment.
• Bring any previous bone age X-ray reports so the radiologist can note the interval change from the prior study.

Emerging Research and the Future of Bone Age Assessment

The field of skeletal maturity assessment is evolving rapidly, driven by advances in artificial intelligence, genetics, and population-level data science.

Multi-site bone assessment is an emerging approach in which AI algorithms simultaneously analyze not just the hand but also the knee, elbow, and hip from a single imaging session to generate a more comprehensive skeletal maturity profile. Early research suggests this approach may reduce assessment error in children whose hand bone age sits at the extremes of the reference range.

MRI-based bone age assessment is a genuinely exciting development that eliminates radiation exposure entirely. MRI (magnetic resonance imaging, a technique using magnetic fields and radio waves rather than ionizing radiation to create detailed images) can visualize growth plate cartilage directly, providing information about plate thickness and signal characteristics that X-rays cannot capture. Pilot studies have shown MRI-derived bone age correlates well with X-ray-based bone age in older children and adolescents. The primary barriers to routine clinical adoption are cost (an MRI costs many times more than a hand X-ray), scanning time (children must remain still for longer), and the need for sedation in young children. Research groups at University of California San Francisco, Cincinnati Children’s Hospital Medical Center, and international centers are actively working to make MRI bone age clinically practical.

Genetics of skeletal maturity is another frontier. Genome-wide association studies (GWAS, large-scale analyses scanning the entire genome for variants linked to a specific trait) have identified hundreds of genetic variants associated with age at puberty onset and growth plate fusion timing. As genetic testing becomes more accessible, it may eventually be possible to generate a personalized expected bone age trajectory based on a child’s genomic profile, improving the precision of height prediction and treatment planning well beyond what population-based reference atlases can currently achieve.

Bone age assessment began as a qualitative comparison between an X-ray and an atlas photograph. It has evolved into a multi-method, AI-supported, hormonally contextualized, and increasingly genomics-informed pillar of pediatric clinical care. The information it provides remains irreplaceable for the hundreds of thousands of U.S. children evaluated for growth concerns each year, and the science supporting it continues to strengthen in ways that will meaningfully improve outcomes for the next generation of patients.

FAQs

What is bone age in simple terms?

Bone age is an estimate of how mature a child’s skeleton is based on an X-ray, rather than how old they are by birthday. It reflects how far the growth plates at the ends of bones have developed and helps doctors understand whether a child’s skeleton is growing at a typical pace.

How is bone age tested?

Bone age is tested using a standard X-ray of the left hand and wrist, which takes less than one second to capture. A radiologist then compares the X-ray image to reference atlases like the Greulich and Pyle atlas or uses AI software to assign a skeletal age in years and months.

What does it mean if bone age is ahead of chronological age?

A bone age more than 2 years ahead of a child’s actual age can indicate precocious puberty, congenital adrenal hyperplasia, or hyperthyroidism. It also means the child may have less remaining growth potential than their current height suggests, so doctors use this finding to guide further evaluation and possible treatment.

What does delayed bone age mean?

A bone age more than 2 years behind chronological age can reflect growth hormone deficiency, hypothyroidism, malnutrition, or celiac disease. In otherwise healthy children it sometimes represents constitutional delay of growth and puberty, a normal variant where the child simply follows a later biological schedule and typically reaches a normal adult height.

At what age do growth plates close?

Growth plates typically fuse between approximately 14 and 15 years of age in girls and 16 and 17 years in boys, though there is natural variation. Once all plates fuse, linear growth stops. The medial clavicle plate is the last to fuse, often completing between ages 25 and 30.

Is a bone age X-ray safe for children?

Yes. The radiation dose from a hand and wrist X-ray is extremely low, approximately 0.00001 Sv, equivalent to a few hours of natural background radiation. It is considered one of the lowest-radiation imaging studies available and is routinely performed even in young children without significant concern.

How accurate is bone age testing?

Manual reading by an experienced radiologist carries an accuracy within roughly plus or minus 1 year for most children. AI-assisted tools like BoneXpert achieve precision of approximately plus or minus 0.5 years. Accuracy tends to be higher for older children and those in mid-to-late puberty than for very young children or infants.

Does bone age testing require a referral?

In most U.S. health care settings, a physician order is required to schedule a bone age X-ray. This is typically initiated by a pediatrician or pediatric endocrinologist. Some insurance plans require a referral specifically to a pediatric endocrinologist before ordering the study to ensure it meets medical necessity criteria.

How much does a bone age X-ray cost in the United States?

Without insurance, a bone age X-ray generally costs between $50 and $200 depending on the facility. Most insurance plans, including Medicaid, cover the test when there is documented clinical justification such as short stature, growth concerns, or endocrine disorder evaluation.

Can bone age predict how tall my child will be?

Yes, with a margin of roughly plus or minus 2 inches (5 cm). Pediatric endocrinologists use formulas like the Bayley-Pinneau method or Roche-Wainer-Thissen formula, combining bone age with current height and parental heights, to estimate final adult stature. These predictions become more reliable as the child gets closer to the end of puberty.

How long does it take to get bone age X-ray results?

Most facilities provide a formal radiology report within 24 to 48 hours. Hospitals and clinics using automated AI platforms may generate a preliminary estimate within minutes of image capture, which a radiologist then reviews and finalizes before signing the official report.

Can bone age be assessed in infants under 2 years old?

Hand and wrist X-rays are less informative for children under 2 years because too few bones have begun ossifying to score reliably. In this age group, clinicians may instead examine the knee or foot, where different ossification centers provide more useful information at that developmental stage.

What is the difference between the Greulich-Pyle and Tanner-Whitehouse methods?

The Greulich-Pyle method compares the entire hand X-ray to atlas photographs and assigns the closest matching age, taking under 5 minutes and making it the preferred method for busy clinical settings. The Tanner-Whitehouse TW3 method scores 20 individual bones separately for greater precision, making it more time-intensive and better suited for research or close monitoring of treatment response.

Is bone age testing the same as a DEXA scan?

No. A bone age X-ray evaluates skeletal maturity by examining growth plate development and is used primarily in children. A DEXA scan (dual-energy X-ray absorptiometry, a technique measuring bone mineral density) assesses bone strength and is used to evaluate osteoporosis risk, primarily in adults. They use different technology and serve entirely different clinical purposes.

Can bone age be used to determine a person’s age for legal purposes?

Bone age can provide an estimated age range in forensic contexts such as immigration hearings or cases involving undocumented minors, but it cannot confirm a precise age to legal certainty. Courts use it as one piece of evidence alongside dental development, physical examination, and available documentation rather than as a definitive age determination.

How does growth hormone therapy use bone age data?

Physicians use serial bone age measurements to decide when to start growth hormone treatment, how to adjust the dose, and when to stop therapy. Treatment is generally discontinued when bone age reaches approximately 14 years in girls or 16 years in boys and growth velocity falls below 2 to 2.5 cm per year, indicating that growth plates are nearly or fully fused.

Does nutrition affect bone age?

Yes. Severe malnutrition, vitamin D deficiency, zinc deficiency, and chronic illnesses like celiac disease or inflammatory bowel disease can delay bone age significantly. Successful treatment of the underlying nutritional deficiency or illness often triggers catch-up growth during which bone age advances more rapidly to partially close the gap with chronological age.

Why is the left hand used instead of another body part?

The left hand is used by convention established through the major reference atlases, not because of any biological difference from the right hand. It contains 29 bones that ossify on a well-documented, predictable schedule, making it the most information-dense and practical single site for skeletal maturity assessment. Standardizing on the left hand ensures comparability across studies, institutions, and time points.

What is constitutional delay of growth and puberty?

Constitutional delay of growth and puberty (CDGP) is a normal growth variant, not a disease, in which a child follows a later biological schedule for puberty and skeletal maturation than most peers. It is one of the most common causes of short stature and delayed bone age seen by pediatric endocrinologists, and it typically runs in families. Most children with CDGP reach a completely normal adult height, just later than their same-age classmates.

Can MRI be used instead of X-ray for bone age?

MRI-based bone age assessment is an active area of research and can visualize growth plate cartilage without radiation. However, it is not yet standard clinical practice in the U.S. due to higher cost, longer scan time, and the need for sedation in young children. X-ray remains the clinical standard, and MRI bone age is currently used primarily in research settings.

How often should bone age be repeated during treatment?

Most pediatric endocrinologists repeat bone age every 6 to 12 months when monitoring a child on growth hormone therapy, treatment for precocious puberty, or management of another condition affecting skeletal maturity. More frequent testing is rarely needed and provides little additional information given the pace at which bone age normally advances.